Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹212 Cr
up ₹8.9 Cr vs Jun 2019
- Stocks held
- 22
- unchanged
- Top 10 weight
- 65.7%
- of the portfolio in its ten largest
- Cash & debt
- 2.6%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 5
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In July 2019 it disclosed 22 stocks worth ₹212 Cr, up ₹8.9 Cr from Jun 2019. Its largest positions were Sun Pharmaceutical Industries Limited (13.8%), IPCA Laboratories Limited (10.2%), Dr. Reddy's Laboratories Limited (8.7%); the ten largest together made up 65.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 69.4% of its equity. Cash and debt stood at 2.6%. Compared with Jun 2019 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
90%
Top-10 weight is higher than 90% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
36%
Holds more cash than 36% of peers
What these mean: concentration · cash
Holdings in July 2019
Download CSVEvery line the fund disclosed, with the change against Jun 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.77% | up 0.26 pts | ₹29.2 Cr | up ₹1.8 Cr | Added |
| IPCA Laboratories Limited | 10.17% | up 0.34 pts | ₹21.6 Cr | up ₹1.6 Cr | Added |
| Dr. Reddy's Laboratories Limited | 8.68% | down 0.30 pts | ₹18.4 Cr | up ₹17 L | Added |
| Divi's Laboratories Limited | 6.95% | down 0.14 pts | ₹14.7 Cr | up ₹33 L | Added |
| Apollo Hospitals Enterprise Limited | 5.43% | up 0.04 pts | ₹11.5 Cr | up ₹56 L | Added |
| Indoco Remedies Limited | 4.92% | up 0.37 pts | ₹10.4 Cr | up ₹1.2 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 4.71% | up 0.23 pts | ₹10 Cr | up ₹89 L | Added |
| Procter & Gamble Health Limited | 3.86% | up 0.40 pts | ₹8.2 Cr | up ₹1.2 Cr | Added |
| Unichem Laboratories Limited | 3.60% | down 0.21 pts | ₹7.6 Cr | down ₹11 L | Trimmed |
| Alembic Pharmaceuticals Limited | 3.56% | up 0.05 pts | ₹7.6 Cr | up ₹42 L | Added |
| Max India Limited | 3.43% | up 0.23 pts | ₹7.3 Cr | up ₹77 L | Added |
| Abiomed Inc | 3.30% | up 0.37 pts | ₹7 Cr | up ₹1.1 Cr | Added |
| Abbott Laboratories | 2.90% | up 0.01 pts | ₹6.1 Cr | up ₹29 L | Added |
| Alkem Laboratories Limited | 2.86% | down <0.01 pts | ₹6.1 Cr | up ₹25 L | Added |
| Jubilant Pharmova Limited | 2.79% | down 0.03 pts | ₹5.9 Cr | up ₹18 L | Added |
| Syngene International Limited | 2.71% | down 0.15 pts | ₹5.7 Cr | down ₹7 L | Trimmed |
| Torrent Pharmaceuticals Limited | 2.58% | up 0.09 pts | ₹5.5 Cr | up ₹41 L | Added |
| Cash, TREPS & receivables | 2.58% | down 0.94 pts | ₹5.5 Cr | down ₹1.7 Cr | Trimmed |
| Ajanta Pharma Limited | 2.57% | down 0.34 pts | ₹5.4 Cr | down ₹46 L | Trimmed |
| Aarti Drugs Limited | 2.56% | down 0.26 pts | ₹5.4 Cr | down ₹29 L | Trimmed |
| Abbott India Limited | 2.51% | down 0.27 pts | ₹5.3 Cr | down ₹33 L | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.17% | up 0.13 pts | ₹4.6 Cr | up ₹47 L | Added |
| Dr. Lal Path Labs Limited | 1.40% | up 0.11 pts | ₹3 Cr | up ₹35 L | Added |
What changed, Jun 2019 to Jul 2019
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹1.8 Cr (+0.26% pts)
- IPCA Laboratories Limitedup ₹1.6 Cr (+0.34% pts)
- Indoco Remedies Limitedup ₹1.2 Cr (+0.37% pts)
- Procter & Gamble Health Limitedup ₹1.2 Cr (+0.40% pts)
- Abiomed Inc ₹1.1 Cr (+0.37% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2019, the weight rose most in Healthcare Services (+0.5 pts) and Insurance (+0.1 pts), and fell most in Pharmaceuticals & Biotechnology (−0.6 pts).
- Healthcare Services16.2% → 16.7%+0.5 pts
- Insurance2.1% → 2.2%+0.1 pts
- Pharmaceuticals & Biotechnology70.0% → 69.4%−0.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2019 | Apr 2019 | Jun 2019 | Jul 2019 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.9% | 70.3% | 70.0% | 69.4% |
| Healthcare Services | 14.7% | 14.8% | 16.2% | 16.7% |
| Pharmaceuticals | 10.0% | 12.6% | 11.7% | 11.7% |
| Insurance | 2.4% | 2.3% | 2.1% | 2.2% |
Allocation in Jul 2019change vs Jun 2019
- Pharmaceuticals & Biotechnology (13)69.4%▼ 0.6 pts
- Healthcare Services (5)16.7%▲ 0.5 pts
- Pharmaceuticals (3)11.7%▲ 0.1 pts
- Insurance (1)2.2%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jul 2019
2.6%
▼ 0.9 pts vs Jun 2019
- Cash alone
- 2.6%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 2.6% – 28.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.